Oscar Health, Inc. (NYSE:OSCR – Get Free Report) CFO Richard Blackley sold 28,869 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $907,930.05. Following the completion of the sale, the chief financial officer owned 1,046,108 shares of the company’s stock, valued at $32,900,096.60. The trade was a 2.69% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Richard Scott Blackley also recently made the following trade(s):
- On Tuesday, August 18th, Richard Blackley sold 18,750 shares of Oscar Health stock. The shares were sold at an average price of $31.74, for a total value of $595,125.00.
Oscar Health Price Performance
Shares of NYSE OSCR traded up $0.65 during mid-day trading on Tuesday, reaching $32.90. The company’s stock had a trading volume of 4,754,751 shares, compared to its average volume of 7,062,275. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $33.55. The stock has a fifty day moving average of $30.49 and a two-hundred day moving average of $22.87. The firm has a market capitalization of $10.15 billion, a PE ratio of 23.50, a P/E/G ratio of 0.66 and a beta of 2.37.
Analyst Ratings Changes
A number of equities analysts recently weighed in on the stock. Zacks Research upgraded shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Wells Fargo & Company lifted their price target on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a report on Thursday, August 13th. Piper Sandler reiterated an “overweight” rating and issued a $36.00 price target on shares of Oscar Health in a research note on Tuesday, July 28th. Barclays increased their price objective on shares of Oscar Health from $35.00 to $39.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $30.00 target price on shares of Oscar Health in a report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $26.22.
View Our Latest Analysis on Oscar Health
Institutional Investors Weigh In On Oscar Health
Several large investors have recently bought and sold shares of OSCR. Nykredit A S bought a new position in Oscar Health during the second quarter valued at $130,000. California State Teachers Retirement System increased its holdings in shares of Oscar Health by 3,214.2% in the 2nd quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company’s stock worth $222,543,000 after buying an additional 7,567,600 shares during the last quarter. Comprehensive Financial Planning Inc. PA purchased a new stake in shares of Oscar Health during the 2nd quarter valued at about $309,000. AXQ Capital LP bought a new position in shares of Oscar Health in the 2nd quarter valued at about $1,059,000. Finally, Wellington Management Group LLP lifted its holdings in shares of Oscar Health by 65.6% in the 2nd quarter. Wellington Management Group LLP now owns 603,675 shares of the company’s stock valued at $17,217,000 after acquiring an additional 239,109 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.
About Oscar Health
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
Recommended Stories
- Five stocks we like better than Oscar Health
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
